Section Arrow
Quote
OBIO.NASDAQ
- Orchestra BioMed Holdings
Quotes are at least 15-min delayed:2025/06/05 05:58 EDT
Last
 3.26
+0.02 (+0.62%)
Day High 
3.49 
Prev. Close
3.24 
1-M High
3.26 
Volume 
424.97K 
Bid
3.26
Ask
3.68
Day Low
3.235 
Open
3.26 
1-M Low
2.37 
Market Cap 
124.13M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.9 
20-SMA 2.83 
50-SMA 3.03 
52-W High 8.8699 
52-W Low 2.37 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.77/-1.66
Enterprise Value
140.11M
Balance Sheet
Book Value Per Share
0.44
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.64M
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CLRBCellectar Biosciences0.4617+0.1841+66.32%-- 
NCNANuCana plc0.0461-0.0137-22.91%-- 
RXRXRecursion Pharmaceuticals4.91+0.52+11.85%-- 
HOTHHoth Therapeutics1.53+0.6102+66.34%-- 
SGMTSagimet Biosciences4.08+0.45+12.40%-- 
Quotes are at least 15-min delayed：2025/06/05 05:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborationswith medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.